Lisby Steen 4
4 · Y-mAbs Therapeutics, Inc. · Filed Jan 30, 2023
Insider Transaction Report
Form 4
Lisby Steen
Sr VP & CMO
Transactions
- Award
Employee Stock Option (right to buy)
2023-01-26+32,000→ 32,000 totalExercise: $4.55Exp: 2033-01-26→ Common stock (32,000 underlying)
Footnotes (2)
- [F1]Stock options granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc.
- [F2]The stock option shall vest and become exercisable as to 25% of the shares subject to the option on January 26, 2024, and thereafter vests and become exercisable as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting.